The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Characterization of Spontaneous and Precipitated Nicotine Withdrawal in the Mouse
Abstract
The nicotine withdrawal syndrome was validated and characterized in the mouse using both somatic and affective measures after infusion with nicotine daily via subcutaneous minipumps. The influence of dose, duration of infusion, and repeated withdrawal as well as the contribution of genetic factors were investigated. We then characterized the contribution of nicotinic receptor and site mechanisms to withdrawal signs using various nicotinic antagonists. Our results showed that spontaneous nicotine withdrawal increased the number of somatic signs, decreased the time spent in open arms of the plus-maze test, and induced hyperalgesia. The effect was dose-dependent in all measures with no significant changes at the lowest dose of nicotine (6 mg/kg/day). Withdrawal signs were prominent shortly after pump removal and remained prominent through day 3 or 4. The results with the different antagonists (mecamylamine, dihydro-beta-erythroidine, and methyllycaconitine) suggest the involvement of several nicotinic subtypes such as alpha3beta4*, alpha4beta2*, and alpha7 in nicotine withdrawal. Increasing the duration of nicotine exposure (from 7 to 60 days) and the total nicotine exposure (increasing doses of infusing) augmented the severity of nicotine withdrawal signs. The withdrawal severity of nicotine differs between C57/BL and 129/SvEv inbred mice with nicotine withdrawal in C57 being more severe than in the 129 strain. In summary, our present results suggest that withdrawal from nicotine can be modulated by genetic factors, daily nicotine intake, duration of nicotine exposure, and withdrawal history. The present study demonstrates that our mouse nicotine withdrawal model will be useful for studying the pharmacological, biochemical, and genetic mechanisms involved in nicotine dependence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rodents chronically exposed to nicotine undergo a characteristic withdrawal syndrome which develops spontaneously, after removing the nicotine source, or can be precipitated by administration of a nAChR antagonist such as mecamylamine [7, 11, 81, 163–166].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [165]
In the citing paper
“Nicotine withdrawal can elicit anxiety-like behaviors in mice [190–192].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [191]
Citations
Cites
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 538
Self-citationRodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334
Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor Subtypes
Papke, R. L., Sanberg, P. R., & Shytle, R. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29581-1 · Cited by 271
Smoking withdrawal dynamics in unaided quitters.
Piasecki, T. M., Niaura, R., Shadel, W. G., Abrams, D., Goldstein, M., Fiore, M. C., & Baker, T. B. (2000) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.109.1.74 · Cited by 262
Acute and chronic tolerance to nicotine measured by activity in rats
Stolerman, I. P., Fink, R. S., & Jarvik, M. E. (1973) · Psychopharmacology · doi:10.1007/bf00429192 · Cited by 246
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214
Cigarette smoking and nicotine addiction
Benowitz, N. L. (1992) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30360-1 · Cited by 152
Cigarette withdrawal symptoms in adolescent smokers
McNeill, A. D., West, R., Jarvis, M. J., Jackson, P., & Bryant, A. (1986) · Psychopharmacology · doi:10.1007/bf00174074 · Cited by 142
RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.
Bencherif, M., Lovette, M. E., Fowler, K., Arrington, S. R., Reeves, L., Caldwell, W. S., & Lippiello, P. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21302-7 · Cited by 141
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 222
Ma, Z., Strecker, R. E., McKenna, J. T., Thakkar, M. M., McCarley, R. W., & Tao, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.074 · Cited by 28
Semenova, S., Contet, C., Roberts, A. J., & Markou, A. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts107 · Cited by 32
Adult mice voluntarily progress to nicotine dependence in an oral self-selection assay
Locklear, L. L., McDonald, C. G., Smith, R. F., & Fryxell, K. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.037 · Cited by 28
Lee, A. M., Mansuri, M. S., Wilson, R. S., Lam, T. T., Nairn, A. C., & Picciotto, M. R. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.657064 · Cited by 23
Tobey, K. M., Walentiny, D. M., Wiley, J. L., Carroll, F. I., Damaj, M. I., Azar, M. R., Koob, G. F., George, O., Harris, L. S., & Vann, R. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2703-3 · Cited by 23
Self-citationHan, J., Wang, D.-S., Liu, S.-B., & Zhao, M. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.113 · Cited by 24
Intrinsic Insular-Frontal Networks Predict Future Nicotine Dependence Severity
Hsu, L., Keeley, R. J., Liang, X., Brynildsen, J. K., Lu, H., Yang, Y., & Stein, E. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0140-19.2019 · Cited by 22
Rao, U., & Chen, L.-A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801010068 · Cited by 22
Multidimensional Intersection of Nicotine, Gene Expression, and Behavior
Sherafat, Y., Bautista, M. R., & Fowler, C. D. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.649129 · Cited by 25
O’Rourke, K. Y., Touchette, J. C., Hartell, E. C., Bade, E. J., & Lee, A. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.023 · Cited by 27
Dawson, A., Miles, M. F., & Damaj, M. I. (2013) · Alcohol · doi:10.1016/j.alcohol.2012.12.004 · Cited by 23
Self-citationJackson, A. B., Papke, R. L., & Damaj, M. I. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4879-7 · Cited by 19
Self-citationCiudad‐Roberts, A., Camarasa, J., Pubill, D., & Escubedo, E. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.02.013 · Cited by 19
Xi, Z., Muldoon, P. P., Wang, X., Bi, G., Damaj, M. I., Lichtman, A. H., Pertwee, R. G., & Gardner, E. L. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14844 · Cited by 19
Self-citationMultiple Motivational Forces Contribute to Nicotine Dependence
Markou, A., & Paterson, N. E. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_5 · Cited by 20
Chellian, R., Behnood‐Rod, A., Wilson, R., Wilks, I., Knight, P., Febo, M., & Bruijnzeel, A. W. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172998 · Cited by 18
Metaxas, A., Keyworth, H. L., Yoo, J.-S., Chen, Y., Kitchen, I., & Bailey, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02023.x · Cited by 18
Nicotine withdrawal and κ-opioid receptors
McCarthy, M. J., Zhang, H., Neff, N. H., & Hadjiconstantinou, M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1674-5 · Cited by 16
Mahmood, H. M., Aldhalaan, H., Alshammari, T. K., Alqasem, M., Alshammari, M. A., Albekairi, N. A., & AlSharari, S. D. (2020) · Autism Research · doi:10.1002/aur.2342 · Cited by 17
Muñoz-Castañeda, R., Díaz, D., Ávila-Zarza, C. A., Alonso, J. R., & Weruaga, E. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3284-5 · Cited by 16
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models
Smith, L. C., & George, O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108225 · Cited by 18
Simmons, S. J., & Gould, T. J. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12171 · Cited by 18
Parikh, V., Cole, R. D., Patel, P., Poole, R. L., & Gould, T. J. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.003 · Cited by 15
Translational Research on Nicotine Dependence
Falcone, M., Lee, B., Lerman, C. E., & Blendy, J. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5005 · Cited by 15
Zhang, X., Pengcheng, X., Li, C., Zhu, W., Wu, S., Yu, A., Ding, Y., Wang, Q., & Zhang, Z. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000769 · Cited by 16
Cole, R. D., Wolsh, C. C., Zimmerman, M., Harrington, E. N., Gould, T. J., & Parikh, V. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.07.019 · Cited by 17
Hamouda, A. K., Bautista, M. R., Akinola, L. S., Alkhlaif, Y., Jackson, A. B., Carper, M., Toma, W. B., Garai, S., Chen, Y.-C., Thakur, G. A., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108568 · Cited by 15
Self-citationJackson, K. J., & Damaj, M. I. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.005 · Cited by 16
Self-citationMuelken, P., Schmidt, C. E., Shelley, D., Tally, L., & Harris, A. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144553 · Cited by 14
Cole, R. D., Zimmerman, M., Matchanova, A., Kutlu, M. G., Gould, T. J., & Parikh, V. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0574-6 · Cited by 15
Saravia, R., Ten-Blanco, M., Pereda-Pérez, I., & Berrendero, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413316 · Cited by 14
Nega, S., Marquez, P. V., Hamid, A., Ahmad, S. M., & Lutfy, K. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24649 · Cited by 14
Varenicline: progress in smoking cessation treatment
Glover, E. D., & Rath, J. M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1757 · Cited by 14
Effects of nicotine and stress exposure across generations in C57BL/6 mice
Yohn, N. L., Caruso, M. J., & Blendy, J. A. (2019) · Stress · doi:10.1080/10253890.2018.1532991 · Cited by 13
Yildirim, E., Connor, D. A., & Gould, T. J. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000111 · Cited by 13
Seemiller, L. R., Logue, S. F., & Gould, T. J. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173429 · Cited by 13
Rehni, A. K., Singh, T. G., & Arora, S. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr228 · Cited by 13
Effects of acute and chronic nicotine on catecholamine neurons of the nucleus of the solitary tract
Page, S. J., Zhu, M., & Appleyard, S. M. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00344.2017 · Cited by 13
Shao, X. M., Liu, S., Lee, E. S., Fung, D., Pei, H., Liang, J., Mudgway, R., Zhang, J., Feldman, J. L., Zhu, Y., et al. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00357.2018 · Cited by 12
Keyworth, H. L., Georgiou, P., Zanos, P., Rueda, A. V. L., Chen, Y., Kitchen, I., Camarini, R., Cropley, M., & Bailey, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14068 · Cited by 12
New medications development for smoking cessation
Lengel, D., & Kenny, P. J. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100103 · Cited by 14
Role of α5-containing nicotinic receptors in neuropathic pain and response to nicotine
Xanthos, D. N., Beiersdorf, J., Thrun, A., Ianosi, B., Orr‐Urtreger, A., Huck, S., & Scholze, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.012 · Cited by 11
Ponzoni, L., Melzi, G., Marabini, L., Martini, A., Petrillo, G., Teh, M., Torres-Pérez, J. V., Morara, S., Gotti, C., Braida, D., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110334 · Cited by 11
Chun, C., Qi, X., Wang, F., Madrid, K., Saldarriaga, L. A., Fisch, M. R., Brantly, M., Upchurch, G. R., & Jiang, Z. (2021) · Journal of Immunology Research · doi:10.1155/2021/6880036 · Cited by 11
Lakosa, A., Rahimian, A., Tomasi, F., Marti, F., Reynolds, L. M., Tochon, L., David, V., Danckaert, A., Canonne, C., Tahraoui, S., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01563-x · Cited by 10
Cheeks, S. N., Buzzi, B., Valdez, A., Mogul, A. S., Damaj, M. I., & Fowler, C. D. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109833 · Cited by 10
Self-citationRehman, N. U., Esmaeilpour, K., Joushi, S., Abbas, M., al‐Rashida, M., Rauf, K., & Masoumi‐Ardakani, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110783 · Cited by 10
Markou, A., Chiamulera, C., & West, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00026-6 · Cited by 10
Keady, J. V., Hessing, M. C., Songrady, J. C., McLaurin, K. A., & Turner, J. R. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00656-6 · Cited by 9
Chronic nicotine exposure alters sperm small RNA content in C57BL/6J mouse model
Zeid, D., & Gould, T. J. (2023) · Developmental Psychobiology · doi:10.1002/dev.22367 · Cited by 9
Kim, B., & Im, H. (2024) · Behavioral and Brain Functions · doi:10.1186/s12993-024-00227-0 · Cited by 9
Hall, B. J., Pearson, L. S., & Buccafusco, J. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.09.009 · Cited by 9
The Neurobiology of Nicotine Addiction: Clinical and Public Policy Implications
Gardner, P. D., Tapper, A. R., King, J. A., DiFranza, J. R., & Ziedonis, D. M. (2009) · Journal of Drug Issues · doi:10.1177/002204260903900211 · Cited by 9
Singh, T. G., Rehni, A. K., & Arora, S. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000009 · Cited by 8
Patel, D. G., Vishwakarma, P. K., Patel, R., & Jain, N. S. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112997 · Cited by 7
Vitamin D3 reduces hippocampal NR2A and anxiety in nicotine withdrawal mice
Wu, B., Tao, X., Liu, C., Li, H., Jiang, T., Chen, Z., Wang, Q., Liu, F., Mu, M., & Chen, Z. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0166 · Cited by 8
Özkan, A. S., Uçar, M., & Akbaş, S. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.06.028 · Cited by 7
Characterization of a novel oronasal-restricted nicotine vaping self-administration model in mice
Akinola, L. S., Buzzi, B., Kalck, E., Le, K., Klein, S., Vaughn, J., Basir, J., Poklis, J. L., Whiteaker, P., Shelton, K. L., et al. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110315 · Cited by 6
Self-citationScientific overview: 2013 BBC plenary symposium on tobacco addiction
Biasi, M. D., McLaughlin, I., Perez, E. E., Crooks, P. A., Dwoskin, L. P., Bardo, M. T., Pentel, P. R., & Hatsukami, D. K. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.05.013 · Cited by 7
Grant, R. A., Cielen, N., Maes, K., Heulens, N., Galli, G. L. J., Janssens, W., Gayan‐Ramirez, G., & Degens, H. (2016) · Behavioural Processes · doi:10.1016/j.beproc.2016.03.021 · Cited by 7
Harris, A. C. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108870 · Cited by 6
Jackson, A. B., Toma, W. B., Contreras, K. M., Alkhlaif, Y., & Damaj, M. I. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.003 · Cited by 6
Self-citationChronic nicotine impairs sparse motor learning via striatal fast‐spiking parvalbumin interneurons
Kim, B. S., & Im, H. (2020) · Addiction Biology · doi:10.1111/adb.12956 · Cited by 8
Shankar, K., Bonnet-Zahedi, S., & George, O. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06852-5 · Cited by 6
Monical, A., & McGehee, D. S. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.2405-24.2025 · Cited by 8
Reynaga, D. D., Cano, M., Belluzzi, J. D., & Leslie, F. M. (2023) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2023.11324 · Cited by 5
Dao, D. Q., Salas, R., & Biasi, M. D. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_18 · Cited by 5
Chen, Y.-C., Rindner, D. J., Fowler, J. P., Lallai, V., Mogul, A. S., Demuro, A., Lür, G., & Fowler, C. D. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1290-23.2023 · Cited by 4
Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice
Singh, T. G., Rehni, A. K., & Arora, S. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0825-0 · Cited by 4
Synthesis of H-bonding probes of α7 nAChR agonist selectivity
Wang, J., Papke, R. L., & Horenstein, N. A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.044 · Cited by 4
Bağdaş, D., Powers, J. M., Rubenstein, D., Sweitzer, M. M., Ditre, J. W., & Weinberger, A. H. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf220 · Cited by 3
Differential roles of diacylglycerol lipase (DAGL) enzymes in nicotine withdrawal
Buzzi, B., Köşeli, E., Alkhlaif, Y., Parker, A., Mustafa, M. A., Lichtman, A. H., Buczynski, M. W., & Damaj, M. I. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148483 · Cited by 3
Self-citationLi, M. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7530-8_5 · Cited by 3
Differential expression of nicotine withdrawal as a function of developmental age in the rat
Keeley, R. J., Mayer, T. E., Hsu, L., Lu, H., Yang, Y., & Stein, E. A. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172802 · Cited by 3
Kwilasz, A. J., Harris, L. S., & Vann, R. E. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.07.015 · Cited by 3
Wing, V. C., Cagniard, B., Murphy, N. P., & Shoaib, M. C. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.017 · Cited by 2
de Moura, F. B., Wilkerson, J. L., & McMahon, L. R. (2020) · Brain and Behavior · doi:10.1002/brb3.1581 · Cited by 2
Kim, B., Kim, H., Woo, J., Lee, H., Kim, T. K., Min, H., Lee, C. J., & Im, H. (2024) · Advanced Science · doi:10.1002/advs.202402274 · Cited by 2
Shrimali, V., Rathore, D., Joshi, A., & Naha, N. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf153 · Cited by 2
Nicotine, Corticotropin-Releasing Factor, and Anxiety-Like Behavior
Bruijnzeel, A. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00020-4 · Cited by 1
(2020) · Indian Journal of Experimental Biology · doi:10.56042/ijeb.v58i06.65499 · Cited by 2
A low dose of nicotine is sufficient to produce nicotine withdrawal in mice
Besson, M., Suárez, S., Changeux, J., & Granon, S. (2010) · Health · doi:10.4236/health.2010.21001 · Cited by 2
Effects of Smoking on Hormones, Brain, and Behavior
Sidhartha, T., Poland, R. E., & Rao, U. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00108-x · Cited by 2
Enhanced Tobacco Use Vulnerability in Adolescents, Females, and Persons With Diabetes
Pipkin, J. A., Ontiveros, T., Carcoba, L. M., & O’Dell, L. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00005-3 · Cited by 1
N-oleoyl alanine attenuates nicotine reward and spontaneous nicotine withdrawal in mice
Karin, K. N., Mustafa, M. A., Poklis, J. L., Buzzi, B., Schlosburg, J. E., Parker, L. A., Damaj, M. I., & Lichtman, A. H. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111276 · Cited by 1
Self-citationThe role of the gut microbiome in nicotine withdrawal and dependence
Köşeli, E., Tyc, K. M., Buzzi, B., Akbarali, H. I., & Damaj, M. I. (2026) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntag057 · Cited by 1
Self-citationTransmitters and Receptors in Nicotine Withdrawal Syndrome
Malin, D. H., Anderson, A. N., & Goyarzu, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00008-9 · Cited by 1
The Habenulo-Interpeduncular Pathway and Nicotine Withdrawal
Fowler, C. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00011-9 · Cited by 1
Rather, I., Behl, T., Sehgal, A., Singh, S., Sharma, N., Sharma, A., Bhatia, S., Al‐Harrasi, A., Khan, N., Khan, H. Z., et al. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17059-4 · Cited by 1
Smith, L. C., Kallupi, M., Tieu, L., Jaquish, A., Barr, J., Su, Y., Velarde, N., Sedighim, S., Klodnicki, M., Carrette, L. L. G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/797084 · Cited by 1
Chronic pain exacerbates nicotine withdrawal severity in a sex-specific and dose-dependent mannerPreprint
Graham, B., Nelson, T., Tavakoli, S., O’Dell, L. E., Addy, N., & Bağdaş, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.16.719070 · Cited by 1
Soll, L. G. (2013) · eScholarship@UMassChan · doi:10.13028/m2ng64
Effects of chronic nicotine on behavioural and neurochemical responses to morphine
Kivinummi, T. (2009) · Työväentutkimus Vuosikirja
Substance Abuse and Dependence
Martín‐García, E., Robledo, P., Cuesta, J., & Maldonado, R. J. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527679348.ch08
Lee, H. J., Shin, S. W., Yang, W. S., Baek, S. H., Kim, C.-H., Kim, H. K., & Baik, S. W. (2007) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2007.53.3.374
Nicotine Preference and Gene Expression: The Role of Cd81
Locklear, L. L. (2011) · ProQuest Demo Repository · doi:10.13021/mars/7534
The Role of Medial Habenula-Interpeduncular Nucleus Pathway in Anxiety: A Dissertation
Pang, X.-Y. (2015) · eScholarship@UMassChan · doi:10.13028/m2vp49
Evaluating the control: minipump implantation and breathing behavior in the neonatal rat.
Kidder, I. J., Mudery, J. A., Barreda, S., Taska, D. J., & Bailey, E. (2016) · Journal of applied physiology · doi:10.1152/japplphysiol.00080.2016
Experimental Studies of Subdiaphragmatic Vagotomy and Nicotine for Reducing Body Weight
Dezfuli, G. (2014) · DigitalGeorgetown (Georgetown University Library)
Ngolab, J. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2730b
Metadata
- Authors
- Damaj, M. I., Kao, W., & Martin, B. R.
- Affiliations
- Virginia Commonwealth University (US)
- ORCID
- Damaj, M.I.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 307
- Issue
- 2
- Pages
- 526-534
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2112994833
- Cited by
- 222
- References
- 24
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 3 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 14 · 2017: 7 · 2016: 15 · 2015: 12 · 2014: 12 · 2013: 14 · 2012: 11
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 05274)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- nicotine withdrawal, nicotine dependence, spontaneous withdrawal, nicotinic acetylcholine receptors, nicotinic receptor subtypes, alpha3beta4 nicotinic receptor, alpha4beta2 nicotinic receptor, alpha7 nicotinic acetylcholine receptor, nicotinic antagonists, mecamylamine, dihydro-beta-erythroidine, methyllycaconitine, hyperalgesia, anxiety-like behavior, inbred mouse strains
- MeSH terms
- Animals, Disease Models, Animal, Male, Mecamylamine, Mice, Inbred ICR, Nicotine, Substance Withdrawal Syndrome, Time Factors, Tobacco Use Disorder, Nicotinic Antagonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review